menu search

Will diagnostic unit weakness mar danaher's (dhr) q3 earnings?

Danaher's (DHR) Q3 results are likely to be hurt by weakness in the Biotechnology and Diagnostics segments due to a decrease in the sale of COVID-rela...

October 16, 2023, 12:02 pm

Pfizer confronts ‘peak of anti-vaccination rhetoric' as shares rebound

Pfizer Inc. PFE, +5.52% on Monday sought to reassure investors that it can slash costs to repair the damage done by underwhelming COVID-19 product sal...

October 16, 2023, 11:05 am

Pfizer (pfe) cuts 2023 outlook as covid products' demand falls

Pfizer (PFE) lowers its total revenue guidance for 2023 by $9 billion as sales from its covid products,...

October 16, 2023, 10:32 am

Pfizer cuts guidance on slumping covid vaccine, treatment sales

"Pfizer (PFE) lowered its 2023 sales forecast on waning covid vaccine demand, but analysts say cost cut...

October 16, 2023, 10:07 am

Asian currencies see falling data amid global conflict

Data on the Chinese yuan notes that lifting Covid-19 restrictions earlier this year has not boosted business transactions as much previously predicted...

October 16, 2023, 9:44 am

Moderna confirms covid sales guidance as shares sink on pfizer news

With its shares under pressure due to revised covid guidance from Pfizer Inc. PFE, +3.38%, Moderna Inc....

October 16, 2023, 9:37 am

Moderna reaffirms annual covid vaccine sales forecast

Moderna on Monday reaffirmed its forecast of $6 billion to $8 billion in covid vaccine sales for the ye...

October 16, 2023, 9:17 am

Pfizer's earnings cut was 'sort of telegraphed', says e squared's les funtleyder

Les Funtleyder, E Squared Capital Management healthcare portfolio manager, joins 'Squawk Box' to discuss Pfizer cutting full-year revenue guidance by ...

October 16, 2023, 8:52 am

Vaccine stocks—including pfizer, moderna, biontech and novavax—slide amid plummeting demand

Pfizer slashed its revenue forecasts on Friday amid falling demand for its covid vaccine and antiviral ...

October 16, 2023, 7:18 am

Assessing the wise & impact covid-19 commercial real estate

The post Assessing the wise & impact COVID-19 commercial real estate appeared first on FinanceBrokerage......

October 16, 2023, 7:17 am

Pfizer and biontech take big write-downs on covid jab stocks

covid vaccine developer BioNTech is to take a write-down of up to €900 million on its stocks of jabs...

October 16, 2023, 6:21 am

Biontech will likely take 900 mln eur write-off on pfizer-partnered vaccines

Germany's BioNTech on Monday said it would likely take write-downs of up to 900 million euros ($947 million) in the third quarter after its partner Pf...

October 16, 2023, 3:59 am

Gilead sciences stock is cheap, with broad pipeline

Gilead Sciences is a California-based biopharmaceutical company with a $95 billion market cap, known for its treatments in HIV, hepatitis B, hepatitis...

October 15, 2023, 9:45 pm

Eu delays approval of novavax's revised covid vaccine - ft

European Union (EU) regulators have delayed the decision to give approval for Novavax's variant-tailored COVID-19 vaccine, the Financial Times said on...

October 15, 2023, 12:24 am

Simon property group: 7.1% yield is not enough

Simon Property Group is the largest owner of shopping malls in the US, but there are better alternatives in the REIT retail segment. The company's rev...

October 14, 2023, 6:08 am

Gritstone bio: renewed excitement for its covid-19 vaccine

GRTS's COVID-19 vaccine may produce more durable immunity than current mRNA vaccines, according to data from phase 1 studies. GRTS has secured a $433 ...

October 14, 2023, 2:21 am

Pfizer slashes outlook: projects weak demand for covid-19 vaccine and paxlovid

Hosted by Brian Sullivan, “Last Call” is a fast-paced, entertaining business show that explores the intersection of money, culture and policy. Tun...

October 13, 2023, 8:31 pm

Pfizer launches $3.5 billion cost-cutting program amid declining covid vaccine sales

The pharmaceutical company warned in January it expected revenue for its covid vaccine and Paxlovid pil...

October 13, 2023, 7:43 pm

Pfizer slashes full-year earnings and revenue guidance as covid treatment, vaccine sales slump

Pfizer said it anticipates sales of its covid treatment Paxlovid and its vaccine will be $9 billion les...

October 13, 2023, 5:47 pm

Pfizer warns of delayed paxlovid commercialization and lower covid demand

CNBC's Angelica Peebles joins 'Closing Bell: Overtime' to discuss Pfizer earnings....

October 13, 2023, 5:16 pm


Search within

Pages Search Results: